OOIR: Observatory of International Research

Papers

(The H4-Index of Brain is 72. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Correction to: Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders	396
Reply: Is postural tachycardia syndrome a psychogenic disorder?; Notes on establishing fear conditioning as causal in the postural orthostatic tachycardia syndrome; Patients with POTS fear that data o	391
Methodological drawbacks in the alleged association between foetal sonographic anomalies and autism	241
Clinical and genetic spectrum of 355 Chinese children with epilepsy: a trio-sequencing-based study	210
‘Seeding’ the idea of early diagnostics in synucleinopathies	209
PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson’s disease models	205
In vivo self-assembled siRNAs ameliorate neurological pathology in TDP-43-associated neurodegenerative disease	199
We’re all in this together: a rejoinder to Masud Husain’s (rant) editorial	192
Clinical and genetic characterization of a progressive RBL2-associated neurodevelopmental disorder	191
‘Hippocampal innate inflammatory gliosis only’ in pharmacoresistant temporal lobe epilepsy	190
Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum	189
Impaired ribosome-associated quality control of C9orf72 arginine-rich dipeptide-repeat proteins	176
Deep brain stimulation: a tale of two targets … and closing the loop	172
The axon initial segment as a source of neuropathic pain	167
De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features	153
Lesion correlates of impaired acoustic-phonetic perception after unilateral left hemisphere stroke	147
Dysregulated cortical excitability and tau phosphorylation in a β3 integrin mouse model of autism	147
Mapping the peripheral immune landscape of Parkinson’s disease patients with single-cell sequencing	145
Dysfunction of the magnocellular subdivision of the visual thalamus in developmental dyslexia	145
Global network and local vulnerabilities underlie brain atrophy across Parkinson’s disease stages	144
Thalamostriatal disconnection underpins long-term seizure freedom in frontal lobe epilepsy surgery	129
Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1	129
Biallelic ADAM22 pathogenic variants cause progressive encephalopathy and infantile-onset refractory epilepsy	128
Dopamine and the dynamics of subthalamic and leg muscle activities in parkinsonian stepping	127
Apathy, effort-based decisions and brain integrity in Alzheimer’s and Parkinson’s diseases	123

Associations between accelerated forgetting, amyloid deposition and brain atrophy in older adults	121
Optogenetic stimulation of the superior colliculus suppresses genetic absence seizures	119
Genetically identical twin-pair difference models support the amyloid cascade hypothesis	116
Trigeminal nerve microstructure is linked with neuroinflammation and brainstem activity in migraine	115
Somatic variants of MAP3K3 are sufficient to cause cerebral and spinal cord cavernous malformations	111
The inferior fronto-occipital fasciculus: bridging phylogeny, ontogeny and functional anatomy	111
Source-sink connectivity: a novel interictal EEG marker for seizure localization	110
ActivatingRAC1variants in the switch II region cause a developmental syndrome and alter neuronal morphology	106
The use of optical coherence tomography in neurology: a review	106
A data-driven study of Alzheimer's disease related amyloid and tau pathology progression	103
Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes	102
Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development	101
The vascular contribution of apolipoprotein E to Alzheimer’s disease	100
Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation	98
Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline	97
From bugs to brain: unravelling the GABA signalling networks in the brain–gut–microbiome axis	95
Diffusion MRI tracks cortical microstructural changes during the early stages of Alzheimer’s disease	94
Speech and language markers of neurodegeneration: a call for global equity	94
Brain repair mechanisms after cell therapy for stroke	94
Correction to: New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy	94
Molecular and clinical spectrum of epilepsy-dyskinesia syndromes: a cross-sectional study of 609 patients	93
Demystifying interictal discharges and seizure initiation in focal epilepsy	92
Reply: Unblinding in the lecanemab trial in Alzheimer’s disease	91
The spectrum of disease and tau pathology of nodding syndrome in Uganda	90
The three deceits of bureaucracy	89
Extra-cranial cholinergic lesions in dementia with Lewy bodies	87
Preclinical type 2 diabetes mellitus subtypes: new insights into diabetes, depression and dementia	86
New mechanistic insights into hereditary spastic paraplegias	86
Biallelic LGI1 and ADAM23 variants cause hippocampal epileptic encephalopathy via the LGI1–ADAM22/23 pathway	84
Normalization of network activity in an epilepsy model with a constitutively active GABBR2 variant	84
Disruption of DNA methylation underpins the neuroinflammation induced by targeted CNS radiotherapy	84
Treatment-resistant recurrent unipolar and bipolar depression: associative learning abnormalities	83
Routes of precursors’ migration in remyelination	82
Multiple sclerosis in Denmark (1950–2023): mean age, sex distribution, incidence and prevalence	82
Multiple lines of evidence for disruption of nuclear lamina and nucleoporins in FUS amyotrophic lateral sclerosis	82
Functional network reorganization precedes apathy in Parkinson’s disease: a neural marker of risk?	82
How COVID-19 affects microvessels in the brain	82
Evolutionary perspectives on mRNA signatures of neurodegeneration-related brain remodelling	81
Natural experiment on neuroinflammatory disease incidence and infection links pre- and post-COVID-19	79
Integrative miRNA–mRNA profiling of human epidermis: unique signature of SCN9A painful neuropathy	79
That which we call cortisol awakening response, by any other word would smell as sweet	78
Biallelic null variants in PNPLA8 cause microcephaly by reducing the number of basal radial glia	77
Genome-wide association study of neuropathological features in Lewy body disease	76
Cytotoxic T cells and plasma cells dominate early in temporal lobe epilepsy with GAD antibodies	76
Activation and sensitization of meningeal nociceptors by PACAP-38: implications for migraine headache	76
The interictal suppression hypothesis is the dominant differentiator of seizure onset zones in focal epilepsy	75
Is glymphatic clearance the secret to restorative sleep?	75
Multimodal mapping of regional brain vulnerability to focal cortical dysplasia	72
Stuttering associated with a pathogenic variant in the chaperone protein cyclophilin 40	72